Creative Biolabs Recombinant Antibodies
Products
Loading...

  1. Home
  2. Gene
  3. EGFR

EGFR

rAbs(649)
Glyco-Abs(5)
MHC(2)
Scaffolds(2)
More+
This gene promotes cell proliferation and differentiation; mediates GPCR regulated induction of protein synthesis. The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer.

Anti-Human EGFR Therapeutic Antibody (Futuximab) (TAB-H35)
Derivation:
Chimeric (human/mouse)
Species Reactivity:
Human
Type:
IgG1 - kappa
Application:
FuncS, IF, Neut, ELISA, FC, IP, ICC
Inquiry
Anti-Human EGFR Therapeutic Antibody (Panitumumab) (TAB-020)
Derivation:
Human
Species Reactivity:
Human
Type:
IgG2 - kappa
Application:
ELISA, IP, FC, FuncS, Neut, IF, ICC
Inquiry
Anti-Human EGFR Therapeutic Antibody (Matuzumab) (TAB-165)
Derivation:
Humanized
Species Reactivity:
Human
Type:
IgG1
Application:
Neut, ELISA, IF, IP, FuncS, FC, ICC
Inquiry
Anti-EGFR Therapeutic Antibody (Nimotuzumab) (TAB-710)
Derivation:
Humanized (from mouse)
Species Reactivity:
Human
Type:
IgG1 - kappa
Application:
ELISA, IP, FC, FuncS, Neut, IF, IHC
Inquiry
Anti-Human EGFR Therapeutic Antibody (Zalutumumab) (TAB-040)
Derivation:
Human
Species Reactivity:
Human
Type:
IgG1 - kappa
Application:
ELISA, FC, IP, FuncS, IF, Neut, ICC
Inquiry
Anti-Human EGFR Therapeutic Antibody (Necitumumab) (TAB-119)
Derivation:
Human
Species Reactivity:
Human
Type:
IgG1 - kappa
Application:
FC, IP, ELISA, Neut, FuncS, IF, WB
Inquiry
Anti-EGFR Therapeutic Antibody (Imgatuzumab) (TAB-753)
Derivation:
Humanized (from rat)
Species Reactivity:
Human
Type:
IgG1 - kappa
Application:
Neut, ELISA, IF, IP, FuncS, FC, WB
Inquiry
Anti-Human EGFR Therapeutic Antibody (Cetuximab) (TAB-003)
Derivation:
Chimeric (mouse/human)
Species Reactivity:
Human
Type:
IgG1 - kappa
Application:
IF, IP, Neut, FuncS, ELISA, FC, ICC
Inquiry
Anti-EGFR immunotoxin D2C7 (scFv)-PE (AGTO-G018E)
Species Reactivity:
Human
Application:
Cytotoxicity assay, Function study
Inquiry
Anti-EGFR immunotoxin D2C7 (scFv)-DT (AGTO-G018D)
Species Reactivity:
Human
Application:
Cytotoxicity assay, Function study
Inquiry
Anti-EGFR immunotoxin D2C7 (scFv)-Gel (AGTO-G018G)
Species Reactivity:
Human
Application:
Cytotoxicity assay, Function study
Inquiry
Anti-EGFR immunotoxin D2C7 (IgG)-PE (AGTO-G019E)
Species Reactivity:
Human
Application:
Cytotoxicity assay, Function study
Inquiry
Anti-EGFR immunotoxin D2C7 (IgG)-DT (AGTO-G019D)
Species Reactivity:
Human
Application:
Cytotoxicity assay, Function study
Inquiry
Anti-EGFR immunotoxin D2C7 (IgG)-Gel (AGTO-G019G)
Species Reactivity:
Human
Application:
Cytotoxicity assay, Function study
Inquiry
Recombinant Anti-EGFR × Anti-FcγRIII Bispecific Antibody (CrossMab) (CROSS-L001)
Targets:
EGFR & FcγRIII
Type:
CrossMab
Application:
FuncS, Promising therapeutic agent
Inquiry
Recombinant Anti-EGFR × Anti-CD3 Bi-specific T-cell engagers (BiTE) (BITE-L013)
Targets:
EGFR & CD3
Type:
BiTE
Application:
FuncS, Promising therapeutic agent
Inquiry
Recombinant Anti-EGFR × Anti-CD3 Bi-specific T-cell engagers (BiTE) (BITE-L050)
Targets:
EGFR & CD3
Type:
BiTE
Application:
FuncS, Promising therapeutic agent
Inquiry
Recombinant Anti-EGFR × Anti-FcγRI Bispecific Antibody (F(ab')2) (FAB-L007)
Targets:
EGFR & FcγRI
Type:
F(ab')2
Application:
FuncS, Promising therapeutic agent
Inquiry
Recombinant Anti-FcαRI × Anti-EGFR Bispecific Antibody (F(ab')2) (FAB-L027)
Targets:
FcαRI & EGFR
Type:
F(ab')2
Application:
FuncS, Promising therapeutic agent
Inquiry
Recombinant Anti-EGFR × Anti-CD2 Bispecific Antibody (F(ab')2) (FAB-L057)
Targets:
EGFR & CD2
Type:
F(ab')2
Application:
FuncS, Promising therapeutic agent
Inquiry
Recombinant Anti-EGFR × Anti-CD28 Bispecific Antibody (F(ab')2) (FAB-L062)
Targets:
EGFR & CD28
Type:
F(ab')2
Application:
FuncS, Promising therapeutic agent
Inquiry